TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of Cabergoline Prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Second-line Prescriptions of Cabergoline for Parkinson's Disease
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of Valvular Fibrosis
Endpoint domain: Adverse events/effects
Primary endpoint: 3-Year Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: Number of cardiac MACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of major cerebral events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of groin complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Composite Equilibrium Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colonic mucosal proliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Yield of clinical diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of intestinal resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Changes in parental perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cmax of Voriconazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCt of Voriconazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in thoracic fluid content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in Cardiac Output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in Cardiac Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: estimated GFR (Glomerular Filtration Ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Acute kidney injury detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Maximum tolerated dose of eribulin mesylate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of eribulin mesylate
Endpoint domain: Adverse events/effects
Primary endpoint: Toxicity profile of eribulin mesylate
Endpoint domain: Adverse events/effects
Primary endpoint: 5 years related survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Time to recovery from organ injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Stress at 5 weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline Burnout at 5 weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline State Anxiety at 5 weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cardiovascular malformations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in sleep quantity and quality measures
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in sleep onset difficulties
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Relative Difference in maximal ADP-induced Platelet Aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Technical Success for Delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Global Composite Score for Cognitive Decline
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: HIV proviral DNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HIV plasma viremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: CD4+ and CD8+ T-cell levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentrations of BHB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in Proviral HIV-1 DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Trials With Correct Classification of Normal Sinus Rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Trials With Correct Classification of AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Interferon (IFN)-Gamma : Interleukin (IL)-4 Ratio in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CD4+FOXP3+CD127- Regulatory T Cell Frequencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adhesion incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral risk factors assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological measures of stress reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Familial hypercholesterolemia cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neuropsychological test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients in remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concurrent validity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Moderate improvement in SRM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-delivery sexuality resumption
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in state anxiety (STAI-S)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in mood state (POMS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of subjects with high quality family health history
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Discomfort assessed by patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of Implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Lead Stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pacing Threshold During and Post Implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensing Amplitude During and Post Implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Impedance Measurements During and Post Implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy Response for Respiratory Decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Efficacy Response for Motor Function Decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression for Bipolar Disorder (CGI-BP-M)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical outcomes of Zika virus infection during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of M4344
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients reaching fasting SMPG target without severe hypoglycemic episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: prevention of nausea and emesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevalence of Neurocognitive troubles HAND
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: self report measure of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quantification of B, T, and NK lymphocyte populations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change of bite force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Steady State Pharmacokinetic Exposure of RIF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of correct application of eye drops
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Maternal infant bonding issues
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sera inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Age of prematurity
Endpoint domain: Mortality/survival
Primary endpoint: Aspiration Risk Grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Intra-abdominal Pressure Rises > 18cmH2O
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of visits with clinical inertia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Concentration of the Active Metabolite of Clopidogrel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Presence of Medical Decision-maker Documentation in the EHR
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Presence of Advance Directive in the EHR
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement in FIQR Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Positive hypersensitivity reaction to skin test
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of the Basophil Activation Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Duration of intravenous vasopressors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS pain scaling differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence of epilepsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of epilepsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long term infertility complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Serious side effects (grade 2 or more)
Endpoint domain: Adverse events/effects
Primary endpoint: CTCAE grade 3-4-5 complications related to the intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Hardness of pancreas texture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trunk imbalance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trunk inclination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pelvic tilting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left Ventricular Filling Pressure More Than 15 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change In Maternal Safe Sleep Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area under the receiver operating characteristic curve for detection of Gleason ≥7 cancers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: solute clearances
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Effectiveness of DCEP regimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of recipient chimerism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of hospital stay postoperatively
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in subject-reported post-surgery pain levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in post-surgery complications related to medications
Endpoint domain: Adverse events/effects
Primary endpoint: Total Daily Opioid Requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PIVKA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with endometriosis detected on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in the Symptom Severity domain of the Zurich Claudication Questionnaire (ZCQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Visual Analog Scale (VAS) for leg pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Re-operation at the treatment level(s) at one year post-procedure
Endpoint domain: Mortality/survival
Primary endpoint: Change in patient pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in patient anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Performance test under hypoxic conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in confidence in the clinical diagnosis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Primary blood stream infections
Endpoint domain: Adverse events/effects
Primary endpoint: Culture negative sepsis
Endpoint domain: Adverse events/effects
Primary endpoint: Bacterial cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Differences in ADC values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Occurrence of Treatment-Emergent Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Investigator's Global Assessment of Tolerability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Globotriaosylceramide (GL-3) Clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Y-BOCs scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global impressions Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of Ticagrelor in Hemodialysis Patients
Endpoint domain: Adverse events/effects
Primary endpoint: adherence to PrEP service
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: adherence to PrEP regimen
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Percentage of Patients With Low-risk Rhabdomyosarcoma in Subset 1 Failure Free at 5 Years
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Patients With Stage 1, Clinical Group IIB or C (Node Positive) or Stage 2 Failure Free at 5 Years
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Patients With Low-risk Rhabdomyosarcoma in Subset 2 Failure Free at 5 Years
Endpoint domain: Mortality/survival
Primary endpoint: Change in MOS SF-36 questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Brief Fatigue Inventory
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Monthly Migraine Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of Recombinant Activated Factor VII
Endpoint domain: Adverse events/effects
Primary endpoint: tumour local control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: HPV Vaccination Initiation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of mature oocytes (metaphase II)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Composite of the Cure Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of stage I labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of antibiotic side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in ROX index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Eczema Area Severity Index (EASI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of HBsAg loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Biochemical Failure-free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Number of Clinicians Prescribing Opioid Drugs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Daily goal achievement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in functional walking capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-72h of Lu AF35700
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of Lu AF35700
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician's Global Assessment of Psoriasis (PGA) of Clear or Almost Clear
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Rhyme awareness subtest score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Alliteration awareness subtest score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Phoneme isolation subtest score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Syllable segmentation test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance in behavioral tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effects in magnetic resonance imaging data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genotype of individual participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CT scan rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Viral Load (VL) < 400
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Insulin Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Recurrence or absence of synechiae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Videofluoroscopic Dysphagia Scale (VDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dependence in Two or More Activities of Daily Living (ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Participants Measured Frail at 1-year Follow up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self Rated Health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence and frequency of intimate partner physical assault
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and frequency of psychological aggression
Endpoint domain: Adverse events/effects
Primary endpoint: Change in pure tone audiometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in the Average LH Pulse Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reliability of measurements for blepharoptosis evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death regardless of cause
Endpoint domain: Mortality/survival
Primary endpoint: Non-fatal AMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Unstable angina pectoris
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Retinal structural features
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal vascular features
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of head-neck-coordination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State-trait anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of patients reaching ACR20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total scores on the Hamilton depression scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: % Body Fat (Boys)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: BMI Z-score (Boys)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: % Body Fat (Girls)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: BMI Z-score (Girls)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Targeted temperature compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes